Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2005
10/06/2005US20050222418 Novel tyloindicines and related processes, pharmaceutical compositions and methods
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222253 Anti-cancer nitro- and thia-fatty acids
10/06/2005US20050222250 Curcumin for the prevention and/or treatment of tissue damage
10/06/2005US20050222244 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222237 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease
10/06/2005US20050222232 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
10/06/2005US20050222224 p53 Inhibitors and therapeutic use of the same
10/06/2005US20050222216 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
10/06/2005US20050222211 S(-)rabeprazole compositions and methods
10/06/2005US20050222206 Pyridinoylpiperidines as 5-ht1f agonists
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222197 Novel pyrazolopyridine derivatives as pharmaceutical agents
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222182 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
10/06/2005US20050222181 Compounds in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
10/06/2005US20050222174 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone
10/06/2005US20050222172 Active ingredient in treating neurodegenerative disease, Alzheimer's disease caused by abnormal enzyme activity
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222138 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
10/06/2005US20050222137 Combination of organic compounds
10/06/2005US20050222087 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell
10/06/2005US20050222085 Quaternised ammonium cyclodextrin compounds
10/06/2005US20050222084 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
10/06/2005US20050222076 Composition for cell proliferation
10/06/2005US20050222041 oligopeptides capable of stimulating neural cell adhesion molecule (NCAM) signalling and/or interfering with cell adhesion, used for treatment of nervous system disorders
10/06/2005US20050222025 Method of inhibiting fibrosis with a somatostatin agonist
10/06/2005US20050222020 Apoptotically active peptides
10/06/2005US20050222001 Stable foamed compositions
10/06/2005US20050221483 Propagating pluripotent stem cells from monocytes; tissue engineering; cell therapy; treating cardiovascular, arteriosclerotic, metabolic and liver disorders; cell expressing albumin protein; cirrhosis of the liver
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050221347 Inhibitors of binding between proteins and macromolecular ligands
10/06/2005US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing
10/06/2005US20050221317 Use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005US20050220906 Pharmaceutical composition for treating rheumatism and the preparation thereof
10/06/2005US20050220850 Topical anhydrous and ethanol-free ascomycin compositions
10/06/2005US20050220844 Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether
10/06/2005US20050220827 Chloasma amelioration composition and dullness amelioration composition
10/06/2005US20050220819 Novel binding epitopes for helicobacter pylori and use thereof
10/06/2005US20050220784 Quinazoline derivatives as medicaments
10/06/2005US20050220780 Pharmaceutical composition having thrombolytic anti-inflammatory and cytoprotective properties
10/06/2005US20050220755 Topical composition based on ion-exchange resins, in particular for treating erythemas
10/06/2005US20050220726 Use of sugar esters in cosmetic and/or pharmaceutical preparations
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2558884A1 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
10/06/2005CA2534445A1 Agent for promoting hgf production comprising heparin-like oligosaccharides
10/05/2005EP1582216A1 Remedy for pemphigoid
10/05/2005EP1582210A2 Compositions and methods for treating or preventing surgical adhesions
10/05/2005EP1582208A2 An amino acid compositions for promoting collagen synthesis
10/05/2005EP1582195A1 Whitening agent, skin preparation for external use and cosmetic
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581533A2 Novel benzonaphthyridines
10/05/2005EP1581172A2 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1269973B1 Hair growth stimulant compositions
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1257280B1 Pharmaceutical combination of micronised drospirenone and an estrogen for hormone replacement therapy
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP1077936B1 Novel analogs of 16-hydroxyeicosatetraenoic acid
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678606A Novel crystals
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678524A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
10/05/2005CN1678332A Novel therapeutic use of polypodium extracts
10/05/2005CN1678330A Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
10/05/2005CN1678323A Use of polyunsaturated ketones for the treatment of psoriasis
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678309A Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region
10/05/2005CN1678299A Composition based on triethyl citrate for the treatment of bacterial infections of the skin
10/05/2005CN1676602A Skin cell with anti-inflammatory activity, and its preparing method and use for skin infective wound surface
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676161A Chinese medicine formulation for treating upper respiratory system disease, skin infection and haemorr hoids and its preparing method
10/05/2005CN1676142A Aloe wound-surface cleaning liquid, and its preparing method and use
10/05/2005CN1676127A Dry-wet integrated external-application formulation for treating burn and empyrosis
10/05/2005CN1221565C Peptides and their derivatives thereof showing cell attachment, spreading and detachment activity
10/05/2005CN1221548C Oxazolidinones having sulfoximine functional group
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221523C Novel di-quaternary ammonium salt compound
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/05/2005CN1221272C Medicine for curing gastropathy and treating trauma and preparation method thereof
10/05/2005CN1221271C Chinese medicinal external preparation for treating ulcer of lower limbs
10/05/2005CN1221263C Gel type medicinal composition for treating acne and preparation process thereof
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 1065